World
Sanofi, Glaxo Join Forces to Develop Coronavirus Vaccine
- Partnership brings together two of the biggest vaccine makers
- Manufacturing is among the key hurdles in race for shot
A Sanofi logo sits on the company's headquarters in Paris.
Photographer: Marlene Awaad/BloombergThis article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Two of the world’s biggest vaccine makers are joining forces to tackle the coronavirus as the number of confirmed infections approaches 2 million worldwide.